Tian'an Pharmaceutical Co Ltd
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chi… Read more
Market Cap & Net Worth: Tian'an Pharmaceutical Co Ltd (TNPH)
Tian'an Pharmaceutical Co Ltd (PINK:TNPH) has a market capitalization of $1.52 Million ($1.52 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50670 globally and #15495 in its home market, demonstrating a -63.46% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tian'an Pharmaceutical Co Ltd's stock price $0.00 by its total outstanding shares 800000000 (800.00 Million).
Tian'an Pharmaceutical Co Ltd Market Cap History: 2015 to 2025
Tian'an Pharmaceutical Co Ltd's market capitalization history from 2015 to 2025. Data shows growth from $80.00K to $1.52 Million (37.15% CAGR).
Tian'an Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tian'an Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
36.96x
Tian'an Pharmaceutical Co Ltd's market cap is 36.96 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $31.20 Million | $7.50K | -$20.45K | 4160.00x | N/A |
| 2023 | $5.28 Million | $142.84K | -$16.03K | 36.96x | N/A |
Competitor Companies of TNPH by Market Capitalization
Companies near Tian'an Pharmaceutical Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Tian'an Pharmaceutical Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Tian'an Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Tian'an Pharmaceutical Co Ltd's market cap moved from $80.00K to $ 1.52 Million, with a yearly change of 37.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.52 Million | -63.46% |
| 2024 | $4.16 Million | -21.21% |
| 2023 | $5.28 Million | -83.08% |
| 2022 | $31.20 Million | -42.65% |
| 2021 | $54.40 Million | +94.29% |
| 2020 | $28.00 Million | +12.90% |
| 2019 | $24.80 Million | -64.97% |
| 2018 | $70.80 Million | +195.00% |
| 2017 | $24.00 Million | -50.00% |
| 2016 | $48.00 Million | +59900.00% |
| 2015 | $80.00K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tian'an Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.52 Million USD |
| MoneyControl | $1.52 Million USD |
| MarketWatch | $1.52 Million USD |
| marketcap.company | $1.52 Million USD |
| Reuters | $1.52 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.